Attempts 0 8 0 8 O
to 9 11 9 11 O
obtain 12 18 12 18 O
bone 19 23 19 23 O
marrow 24 30 24 30 O
either 31 37 31 37 O
by 38 40 38 40 O
aspirate 41 49 41 49 O
or 50 52 50 52 O
biopsy 53 59 53 59 B-treatment
must 60 64 60 64 O
be 65 67 65 67 O
made 68 72 68 72 O
unless 73 79 73 79 O
clinically 80 90 80 90 O
prohibitive 91 102 91 102 O
; 102 103 102 103 O

Children 0 8 104 112 O
who 9 12 113 116 O
have 13 17 117 121 O
previously 18 28 122 132 O
received 29 37 133 141 O
chemotherapy 38 50 142 154 B-treatment
, 50 51 154 155 O
radiation 52 61 156 165 B-treatment
therapy 62 69 166 173 I-treatment
or 70 72 174 176 O
any 73 76 177 180 O
anti 77 81 181 185 B-treatment
- 81 82 185 186 I-treatment
leukemic 82 90 186 194 I-treatment
therapy 91 98 195 202 I-treatment
are 99 102 203 206 O
not 103 106 207 210 O
eligible 107 115 211 219 O
for 116 119 220 223 O
this 120 124 224 228 O
protocol 125 133 229 237 O
, 133 134 237 238 O
with 135 139 239 243 O
the 140 143 244 247 O
exception 144 153 248 257 O
of 154 156 258 260 O
cytarabine 157 167 261 271 B-treatment
for 168 171 272 275 O
the 172 175 276 279 O
treatment 176 185 280 289 B-treatment
of 186 188 290 292 O
TMD 189 192 293 296 B-chronic_disease

Patients 0 8 297 305 O
= 9 10 306 307 O
< 10 11 307 308 O
30 12 14 309 311 B-upper_bound
days 15 19 312 316 I-upper_bound
from 20 24 317 321 O
the 25 28 322 325 O
last 29 33 326 330 O
dose 34 38 331 335 O
of 39 41 336 338 O
cytarabine 42 52 339 349 B-treatment
used 53 57 350 354 O
for 58 61 355 358 O
treatment 62 71 359 368 B-treatment
of 72 74 369 371 O
TMD 75 78 372 375 B-chronic_disease

Patients 0 8 376 384 O
has 9 12 385 388 O
cytopenias 13 23 389 399 B-chronic_disease
and/or 24 30 400 406 O
bone 31 35 407 411 O
marrow 36 42 412 418 B-clinical_variable
blasts 43 49 419 425 I-clinical_variable
but 50 53 426 429 O
does 54 58 430 434 O
not 59 62 435 438 O
meet 63 67 439 443 O
the 68 71 444 447 O
criteria 72 80 448 456 O
for 81 84 457 460 O
the 85 88 461 464 O
diagnosis 89 98 465 474 O
of 99 101 475 477 O
AML 102 105 478 481 B-cancer
( 106 107 482 483 O
WHO 107 110 483 486 O
Myeloid 111 118 487 494 O
Neoplasm 119 127 495 503 O
classification 128 142 504 518 O
) 142 143 518 519 O
because 144 151 520 527 O
of 152 154 528 530 O
< 155 156 531 532 O
20 157 159 533 535 B-upper_bound
% 159 160 535 536 I-upper_bound
marrow 161 167 537 543 O
blasts 168 174 544 550 O
and 175 178 551 554 O
meets 179 184 555 560 O
the 185 188 561 564 O
criteria 189 197 565 573 O
for 198 201 574 577 O
a 202 203 578 579 O
diagnosis 204 213 580 589 O
of 214 216 590 592 O
myelodysplastic 217 232 593 608 B-cancer
syndrome 233 241 609 617 I-cancer
( 242 243 618 619 I-cancer
MDS 243 246 619 622 I-cancer
) 246 247 622 623 I-cancer

Patients 0 8 624 632 O
has 9 12 633 636 O
previously 13 23 637 647 O
untreated 24 33 648 657 O
de 34 36 658 660 O
novo 37 41 661 665 O
AML 42 45 666 669 B-cancer
and 46 49 670 673 O
meets 50 55 674 679 O
the 56 59 680 683 O
criteria 60 68 684 692 O
for 69 72 693 696 O
AML 73 76 697 700 O
with 77 81 701 705 O
> 82 83 706 707 O
= 83 84 707 708 O
20 85 87 709 711 B-lower_bound
% 87 88 711 712 I-lower_bound
bone 89 93 713 717 O
marrow 94 100 718 724 O
blasts 101 107 725 731 O
as 108 110 732 734 O
set 111 114 735 738 O
out 115 118 739 742 O
in 119 121 743 745 O
the 122 125 746 749 O
World 126 131 750 755 O
Health 132 138 756 762 O
Organization 139 151 763 775 O
( 152 153 776 777 O
WHO 153 156 777 780 O
) 156 157 780 781 O
Myeloid 158 165 782 789 O
Neoplasm 166 174 790 798 O
classification 175 189 799 813 O

Patients 0 8 814 822 O
must 9 13 823 827 O
have 14 18 828 832 O
constitutional 19 33 833 847 O
trisomy 34 41 848 855 B-chronic_disease
21 42 44 856 858 I-chronic_disease
( 45 46 859 860 I-chronic_disease
Down 46 50 860 864 I-chronic_disease
syndrome 51 59 865 873 I-chronic_disease
) 59 60 873 874 I-chronic_disease
or 61 63 875 877 O
trisomy 64 71 878 885 B-chronic_disease
21 72 74 886 888 I-chronic_disease
mosaicism 75 84 889 898 I-chronic_disease
( 85 86 899 900 O
by 86 88 900 902 O
karyotype 89 98 903 912 O
or 99 101 913 915 O
fluorescence 102 114 916 928 B-treatment
in 115 117 929 931 I-treatment
situ 118 122 932 936 I-treatment
hybridization 123 136 937 950 I-treatment
[ 137 138 951 952 I-treatment
FISH 138 142 952 956 I-treatment
] 142 143 956 957 I-treatment
) 143 144 957 958 O

Patients 0 8 959 967 O
with 9 13 968 972 O
promyelocytic 14 27 973 986 B-cancer
leukemia 28 36 987 995 I-cancer
( 37 38 996 997 O
French 38 44 997 1003 O
- 44 45 1003 1004 O
American 45 53 1004 1012 O
- 53 54 1012 1013 O
British 54 61 1013 1020 O
[ 62 63 1021 1022 O
FAB 63 66 1022 1025 O
] 66 67 1025 1026 O
M3 68 70 1027 1029 O
) 70 71 1029 1030 O

Previous 0 8 1031 1039 B-treatment
cardiac 9 16 1040 1047 I-treatment
repair 17 23 1048 1054 I-treatment
with 24 28 1055 1059 O
sufficient 29 39 1060 1070 O
cardiac 40 47 1071 1078 O
function 48 56 1079 1087 O

Prior 0 5 1088 1093 B-treatment
therapy 6 13 1094 1101 I-treatment

peripheral 0 10 1102 1112 O
blood 11 16 1113 1118 O
with 17 21 1119 1123 O
an 22 24 1124 1126 O
excess 25 31 1127 1133 O
of 32 34 1134 1136 O
20 35 37 1137 1139 O
% 37 38 1139 1140 O
blasts 39 45 1141 1147 O
and 46 49 1148 1151 O
in 50 52 1152 1154 O
which 53 58 1155 1160 O
adequate 59 67 1161 1169 O
flow 68 72 1170 1174 B-treatment
cytometric 73 83 1175 1185 I-treatment
and 84 87 1186 1189 O
cytogenetics 88 100 1190 1202 B-treatment
/ 100 101 1202 1203 O
FISH 101 105 1203 1207 B-treatment
testing 106 113 1208 1215 O
is 114 116 1216 1218 O
feasible 117 125 1219 1227 O
can 126 129 1228 1231 O
be 130 132 1232 1234 O
substituted 133 144 1235 1246 O
for 145 148 1247 1250 O
the 149 152 1251 1254 O
marrow 153 159 1255 1261 O
exam 160 164 1262 1266 O
at 165 167 1267 1269 O
diagnosis 168 177 1270 1279 O

